LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-05
Case ID: NM_004329.3_c.1420G_C_20261105_021748
Framework: ACMG/AMP 2015
Variant classification summary

NM_004329.3:c.1420G>C

BMPR1A  · NP_004320.2:p.(Val474Leu)  · NM_004329.3
GRCh37: chr10:88683210 G>C  ·  GRCh38: chr10:86923453 G>C
Gene: BMPR1A Transcript: NM_004329.3
Final call
VUS
PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
BMPR1A
Transcript
NM_004329.3
Protein
NP_004320.2:p.(Val474Leu)
gnomAD AF
7.68163346218654e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: gnomAD v4.1 grpmax FAF is 0.00008424, below the generic supporting threshold of 0.0001.
Final determination: Under generic ACMG/AMP 2015 rules, one supporting criterion alone satisfies none of the pathogenic, likely pathogenic, benign, or likely benign combinations, so the call is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not met Not met: no established pathogenic BMPR1A variant causing p.Val474Leu was identified, while the exact variant has conflicting ClinVar submissions.
clinvar PMID:25980754
PS2 Not assessed Not assessed: no documented proband phenotype, family history, or confirmed maternity and paternity testing establishes a de novo occurrence.
PS3 Not assessed Not assessed: no variant-specific validated functional assay or reviewed functional evidence was identified for BMPR1A c.1420G>C (p.Val474Leu).
oncokb PMID:25980754 PMID:25741868
PS4 Not met Not met: no exact-variant affected-versus-control counts, odds ratio, or 95% confidence interval were reported to satisfy OR >5.0 with CI excluding 1.0.
PMID:25980754 PMID:15604628
PM1 Not assessed Not assessed: p.Val474Leu may lie in an annotated kinase domain, but a well-established critical domain without benign variation is not documented.
clinvar
PM2 Met Met at supporting strength: gnomAD v4.1 grpmax FAF is 0.00008424, below the <=0.0001 PM2 threshold.
gnomad_v2 gnomad_v4 PMID:25741868
PM3 Not assessed Not assessed: inheritance mode, a pathogenic second allele, affected-proband data, and parent or offspring phase testing are not documented.
PMID:15604628
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: no different pathogenic missense change at BMPR1A residue Val474 is documented in the available evidence.
clinvar PMID:25980754
PM6 Not assessed Not assessed: no documented assumed de novo occurrence or parental testing is available for this variant.
PP1 Not assessed Not assessed: no affected relatives, matching phenotypes, variant genotypes, or informative meioses are documented.
PP2 Not assessed Not assessed: BMPR1A loss-of-function disease evidence is available, but no benign-missense rate and common-missense-mechanism evidence are documented.
pvs1_gene_context
PP3 Not met Not met: missense REVEL score 0.454 is below the generic PP3 supporting threshold of >=0.644.
revel
PP4 Not assessed Not assessed: the patient's phenotype and family history are not provided, so specificity for a single BMPR1A-related disease etiology cannot be judged.
PP5 Not met Not met: ClinVar has zero expert-panel submissions and no exact-variant Pathogenic or Likely pathogenic expert-panel classification.
clinvar PMID:25980754
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.00008424, far below the 0.05 BA1 threshold.
gnomad_v2 gnomad_v4
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.00008424, below the generic 0.01 BS1 threshold.
gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: gnomAD reports 0 homozygotes but no documented healthy adult carrier with age and phenotype information.
gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no variant-specific validated assay showing preserved BMPR1A protein function or splicing was identified for c.1420G>C (p.Val474Leu).
oncokb PMID:25980754 PMID:25741868
BS4 Not assessed Not assessed: no tested affected relatives lacking the variant are documented, and phenocopy or multiple-variant explanations cannot be evaluated.
BP1 Not assessed Not assessed: BMPR1A loss-of-function evidence exists, but the evidence does not show that disease is caused primarily by truncating variants.
pvs1_gene_context
BP2 Not assessed Not assessed: no individual-level co-occurrence with a pathogenic variant or phase result establishes cis or trans for this variant.
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: missense REVEL score 0.454 exceeds the generic BP4 supporting threshold of <=0.29.
revel
BP5 Not assessed Not assessed: no case-level alternate molecular diagnosis or second causal variant is documented for this patient.
BP6 Not met Not met: the benign and likely benign ClinVar assertions are single-laboratory submissions, with zero exact-variant expert-panel submissions.
clinvar PMID:25980754
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.